Molecular Therapy—Oncolytics is an international, online-only, open-access journal focusing on the development and clinical testing of viral, cellular, and other biological therapies targeting cancer. While providing a unique forum for work in the burgeoning fields of oncolytic virotherapy, as well as T cell- and stem cell-based therapies, the journal will consider all top-quality, cutting-edge research that employs innovative molecular and cellular approaches that target cancer cells for destruction, whether by viruses, other microorganisms, vaccination, or transfer of cells and/or genes. As an official journal of the American Society of Gene & Cell Therapy, Molecular Therapy—Oncolytics will build upon the success of Molecular Therapy and its sibling journals in publishing important peer-reviewed original research and editorial commentary.
| YEAR | Impact Factor |
|---|---|
| 2023-24 | 5.3 |
| 2022 | NA |
| 2021 | NA |
Molecular Therapy Oncolytics, 2372-7705, 2016-ongoing, Biochemistry, Genetics and Molecular Biology,Medicine.